Latest Article on Diabetes
Empagliflozin in real-world clinical care
Why is Considering the Heart Essential for People Living with T2D?
From diagnosis to everyday living
Jardiance® (empagliflozin) approved in Europe for the treatment of heart failure with reduced ejection fraction
CARMELINA® subgroup analysis supports long-term cardiovascular and renal safety of linagliptin in older people with type 2 diabetes
Links
Heart Talks
Heart Failure Matters
Downloads
Diabetic Retinopathy
Harold and Dorothy Patient Discussion Factsheet
Type 2 Diabetes
1 Diabetes Atlas 8th edition 2017, International Diabetes Federation. http://www.diabetesatlas.org (accessed Jan 2019)